-
A third inhaled corticosteroid and long-acting beta-agonist combination has been approved by the FDA, joining currently marked combinations fluticasone/salmeterol (Advair Diskus®) and budesonide/formoterol (Symbicort®). Mometasone furoate and formoterol fumarate is marketed by Schering as Dulera®
-
Clinicians are increasingly presented with the tasks of addressing not only a burgeoning population of type 2 diabetics, but an equally voluminous group of prediabetics.
-
-
When complaints of dizziness in elderly patients were evaluated in primary care offices, the most common cause was cardiovascular disease, combined with contributions from adverse drug reactions. This contradicts many previous studies done in tertiary care settings where vertigo or vestibular disease was found to be the most common cause.
-
-
Peripheral arterial disease (PAD) is a pathological condition characterized by atherosclerotic occlusion of arterial blood supply to the lower or upper extremities.
-
-
WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.
-
Obsessive-compulsive disorders have achieved greater visibility in our society with several well-known celebrities such as Howie Mandel and David Beckham with acknowledged cases. Patients may be reluctant to share their symptoms with their primary care physician for fear of being thought crazy. Hopefully today the increased recognition with celebrities and greater media attention to the disorder will resolve this fear and allow patients to become more open with their doctors.
-
Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
